Navigation Links
Biomerix Corporation and Gel Company Announce Strategic Distribution Agreement
Date:7/19/2011

FREMONT, Calif., July 19, 2011 /PRNewswire/ -- Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.

The Biomerix 3D Scaffold consists of a non-degradable, open-cell polycarbonate polyurethane, designed to mimic the nature and function of the extracellular matrix (ECM). Its unique three-dimensional microarchitecture embodies a network of interconnecting cells and pores constructed to support tissue ingrowth, allowing researchers to study cells in an environment that simulates the conditions of cells in the body.  The unique chemistry and macroporous structure of the Biomerix 3D Scaffold supports the growth of myriad cell types and delivers more predictive results compared to standard 2D cell culture systems.  The proprietary Biomerix Biomaterial, used to manufacture the Biomerix 3D Scaffold has been demonstrated to support optimal cell proliferation and superior cell viability in both in-vitro and in-vivo studies and has received seven US and international regulatory clearances for a variety of indications.

"We have already experienced interest in the Biomerix 3D Scaffold, and we are delighted to add this innovative technology to our portfolio of products," said Greg Richardson, President of the Gel Company. "The Biomerix 3D Scaffold is an excellent fit with our expertise in the life science research community."

"Biomerix is very pleased to have the Gel Company become one of our distribution partners.  Their reputation as a quality supplier, as well as their commitment to customer service, was appealing to Biomerix," stated Kenneth Hayes, President and Chief Executive Officer of Biomerix Corporation.  "We look forward to a long and prosperous partnership with the Gel Company."

About Biomerix Corporation

Biomerix Corporation is recognized as a leader in the development and manufacturing of innovative non-absorbable and bioresorbable three-dimensional, open-cell, resilient elastomeric polyurethane biomaterials.  The Company's expertise includes the development, co-development and supply of new proprietary materials, products and components to customers in the medical, industrial and consumer industry markets.

For more information please visit www.biomerix.com or call 888.308.3620.

About Gel Company

Gel Company develops, manufactures and supplies innovative tools for Proteomics, Genomics, Cell Biology, Liquid Handling and Microarray to scientists around the world.  We provide products with superior performance that are simple, safe to use and that are environmentally friendly.  The company has a team of experienced scientists dedicated to developing new technologies and products as well as providing the highest level of customer support.

For more information please visit www.gelcompany.com.


'/>"/>
SOURCE Biomerix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomerix Awarded Two Device Licenses by Health Canada
2. Biomerix Granted CE Mark for its REVIVE™ Soft Tissue Repair Mesh
3. Biomerix Ventral Hernia Repair Mesh Receives FDA 510(k) Clearance
4. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
5. QuantRx Biomedical Corporation Provides Corporate Update
6. American Scientific Resources and School Health Corporation to Supply The Disintegrator™ Needle Destruction Device to Texas School District
7. China Medicine Corporation to Restate Financial Statements for 2006 and 2007
8. CVS Caremark Corporation Announces Quarterly Dividend
9. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
10. Curaxis Pharmaceutical Corporation Announces Key Changes to Its Board of Directors and Management Team in Progression Toward Clinical Trials
11. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
(Date:6/23/2016)...  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member.  ... president and chief scientific officer, Mallinckrodt Pharmaceuticals, will ... Board of Directors. ... us in support of our efforts to conduct ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):